Evidence map›Paper›PMID 42081610›Full record

ArticleChemistry & biodiversity2026

Natural Coumarins Galbanic Acid and Auraptene Improved the Efficacy of Alkeran on Human Osteosarcoma Cells by Targeting ABC Transporters.

Parastoo Azadbeigi, Sara Seyedshazileh, Ahmadreza Gharaiean-Morshed, Mehrdad Iranshahi, Fatemeh B Rassouli

Abstract read
In one paragraph

Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Parastoo AzadbeigiDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Sara SeyedshazilehDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Ahmadreza Gharaiean-MorshedDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Mehrdad IranshahiBiotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Fatemeh B RassouliDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.ORCID https://orcid.org/0000-0003-1889-0964

Funding

Ferdowsi University of Mashhad
6 · The paper itself

Abstract

Osteosarcoma is a severe bone malignancy, and current chemotherapeutic strategies often struggle to effectively halt disease progression. Galbanic acid (GBA) and auraptene (AUR) are natural sesquiterpene coumarins known for their diverse pharmacological activities. This study is the first to evaluate the ability of GBA and AUR to enhance Alkeran-induced toxicity in osteosarcoma cells. GBA and AUR were isolated from Ferula szowitsiana, and the viability and apoptosis of osteosarcoma cells were assessed following treatments with GBA, AUR, and Alkeran-alone and in combination. An efflux assay was conducted to determine the functional interactions of AUR and GBA with ABC transporters, and molecular docking and dynamics simulations were performed to explore their potential interactions. Single treatment of cells with each agent did not induce significant toxicity: however, combination treatments of GBA or AUR with Alkeran significantly (p < 0.0001) reduced cell viability. Synergistic interaction was strong for both coumarins and Alkeran, supported by flow cytometry detection of apoptosis and ABC transporter activity. Molecular docking and dynamics simulations demonstrated favorable and stable interactions of coumarins with ABC transporters. In conclusion, this study provides strong support that GBA and AUR enhanced Alkeran efficacy in osteosarcoma cells by targeting ABC transporters.

Indexed as

Antineoplastic Agents, PhytogenicATP-Binding Cassette TransportersBiological ProductsCoumarinsOsteosarcomaApoptosisCell Line, TumorCell ProliferationCell SurvivalDrug Screening Assays, AntitumorFerulaHumansMolecular Docking SimulationMolecular StructureStructure-Activity RelationshipAntineoplastic Agents, PhytogenicATP-Binding Cassette TransportersauraptenBiological ProductsCoumarinsgalbanic acidABC transportersalkeranauraptenecombination treatmentgalbanic acidosteosarcoma

Identifiers

PMID42081610
PMCPMC13376708

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.